The novel 3‐nitro‐9‐oxo‐9H‐xanthene‐ and 3‐nitro‐9‐oxo‐9H‐thioxanthene‐l‐carboxylic acids 2a–d were prepared by intramolecular acylation of 3‐aryloxy‐ and 3‐arylthio‐5‐nitrophthalic anhydrides 1 (Scheme). The 3‐nitro group was readily substituted by O‐ and S‐nucleophiles and halide and azide ions to give a range of 3‐substituted thioxanthone derivatives 3 with varied λmax.
No takes yet. Share an insight, caveat, or question.
Fischer et al. (1985) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: